Drug Discovery & Pharmaceuticals

RSS

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S, to discover novel small molecule leads for multiple therapeutic targets of interest to LEO Pharma.

7 Aug 2017

Vascularized 3D bioprinted liver tissue offers more accurate system for drug toxicity testing

Artificially constructed human tissues and organs have been developed with a number of different purposes in mind, from advanced robotics and novel materials to drug screening.

3 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

Botulinum toxins are currently used on more than 80 medical conditions including Muscle spasms, Overactive bladder, Chronic migraine, Cervical dystonia, Sweating and Cerebral Palsy (CP).

3 Aug 2017

New partnership uses artificial intelligence methods to develop solutions for preventing early aging

Center for Healthy Aging at the University of Copenhagen today announced a research collaboration with a company specializing in artificial intelligence (AI) to develop solutions for preventing early aging.

1 Aug 2017

Bringing highly potent cell therapy products to market

There are two main challenges and both relate to manufacturing. The first one is to make sure you can manufacture therapies with reasonable costs and the second one is to make sure that you can balance the capacity you need with the demands.

31 Jul 2017

Methamphetamine use does not only cause death through overdose, warn researchers

Overdose is not the only cause of death among people who die as a result of using the drug methamphetamine or “ice,” say researchers.

31 Jul 2017

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Insilico Medicine, a Baltimore-based leader in artificial intelligence for drug discovery and biomarker development, is pleased to announce a multi-year drug development agreement with the biotechnology company Juvenescence AI Limited.

28 Jul 2017

New compound takes positive step toward creating drug for melanoma

While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward creating a drug that can kill melanoma cancer cells without harming nearby healthy cells.

26 Jul 2017

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

A study published in the New England Journal of Medicine on 20th July 2017 suggests that a cocktail of drugs, if provided at the beginning of the HIV therapy, can save over 10,000 lives per year. HIV, which is often diagnosed late, leaves people vulnerable to other diseases by ravaging the immune system.

25 Jul 2017

UNC receives $5.6 million from NIH to test therapeutic HIV vaccine

A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health to test a therapeutic vaccine in people living with HIV.

24 Jul 2017

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

INTEGRA has published a new video that demonstrates how US-based biotech contract research specialists Likarda LLC are using their VIAFLO ASSIST to cost effectively develop high throughput cell based assays for their customers.

From INTEGRA Biosciences 24 Jul 2017

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Antibodies against the Human Immunodeficiency Virus (HIV) have been obtained for the first time by injecting cows with an HIV antigen. This achievement offers promise for the development of anti-HIV treatments or vaccines.

21 Jul 2017

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Municipal wastewater may become a key ally in the fight against antibiotic-resistant disease-causing bacteria and fungi, a new study at Stellenbosch University found.

20 Jul 2017

Methicillin use not to blame for MRSA, say researchers

The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by the University of St Andrews, University of Dundee and the Wellcome Trust Sanger Institute, MRSA existed long before clinicians started using the antibiotic.

20 Jul 2017

Avantor opens new state-of-the-art Innovation Center in Bridgewater, New Jersey

Avantor, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, has opened a new research center in Bridgewater, New Jersey (USA) to help biopharmaceutical and pharmaceutical customers with a full range of upstream and downstream processes, from gene to protein expression through final formulation and drug delivery.

20 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

Developing software for cell and gene therapy supply chain tracking

The first thing is, to always remember that we're dealing with a living drug, cells, which are very sensitive to environmental conditions, such as temperature and humidity etc. All of those things can impact on the viability of the drug and its effectiveness.

18 Jul 2017

New bioanalytical method could pave way for personalized drug therapy

Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients' needs, are getting more and more important.

17 Jul 2017

NIH researchers show how investigational drug works against rare, fatal genetic disease

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

17 Jul 2017

Drug Discovery & Pharmaceuticals

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

Vascularized 3D bioprinted liver tissue offers more accurate system for drug toxicity testing

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

New partnership uses artificial intelligence methods to develop solutions for preventing early aging

Bringing highly potent cell therapy products to market

Methamphetamine use does not only cause death through overdose, warn researchers

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

New compound takes positive step toward creating drug for melanoma

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

UNC receives $5.6 million from NIH to test therapeutic HIV vaccine

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Methicillin use not to blame for MRSA, say researchers

Avantor opens new state-of-the-art Innovation Center in Bridgewater, New Jersey

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

Developing software for cell and gene therapy supply chain tracking

New bioanalytical method could pave way for personalized drug therapy

NIH researchers show how investigational drug works against rare, fatal genetic disease

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News